Revenue Increased 7% (8% Organic)

Steve Silver and Todd Rosenbluth of S&P Capital IQ will discuss the factors behind the recent run-up in biotech equities, how long it might last, and the pros and cons of biotech ETFs

Independent Data Brings Greater Transparency to Markets

"Bridging the U.S. Boom: Global Markets Prepare" to be held December 12 in NYC

On a year-over-year basis, November prices were up 22.0%

Three Cities Saw Default Rates Decreased in September 2013